Tempest Therapeutics, Inc. Current Assets
Tempest Therapeutics, Inc. (TPST) had Current Assets of $1.70 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $1.70M.
- 2026-03-31: Assets, Current $2.45M.
- 2025-12-31: Assets, Current $8.27M.
- 2025-09-30: Assets, Current $8.10M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.70M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $2.45M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $8.27M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $8.10M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $15.10M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $22.43M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $31.47M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $23.55M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $31.55M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $33.50M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $40.36M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $12.29M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $18.54M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $24.67M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $32.95M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $60.26M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $68.31M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $62.71M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $68.96M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $62.56M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $70.49M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $68.96M 10-Q · filed 2022-05-13 | $29.39M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $19.82M 10-K · filed 2022-03-29 | $40.90M 10-K · filed 2021-03-29 |
| 2020-09-30 | $19.82M 10-Q · filed 2021-11-10 | $46.09M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $54.07M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $64.62M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $71.13M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $53.65M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $64.51M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $72.74M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $83.42M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $48.99M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $54.17M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $59.13M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $19.74M 10-K · filed 2019-04-01 | $68.78M 10-K · filed 2018-03-15 |
| 2017-09-30 | $77.61M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $89.09M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $101.15M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $116.44M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $133.45M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $150.11M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $112.74M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $129.86M 10-K · filed 2017-03-02 | |
| 2015-09-30 | $145.32M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $159.16M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $171.33M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $61.88M 10-K · filed 2016-02-26 | |
| 2014-09-30 | $73.61M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $82.61M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $90.07M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $45.08M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $50.41M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $55.26M 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $60.18M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $31.96M 10-K · filed 2014-02-27 | |
| 2012-09-30 | $35.58M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $34.28M 10-Q · filed 2012-08-14 | |
| 2011-12-31 | $4.58M 10-K · filed 2013-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |